Obesity is not primarily about will power.
A sweeping analysis of NHS records covering nearly 55 million English adults reveals that obesity has ceased to be a broadly shared condition and has become a concentrated marker of economic and geographic disadvantage. Since the pandemic, rates have climbed 4 percent overall, but the true weight of the crisis falls on the young, the poor, and those in England's struggling northern regions — where prevalence runs six times higher than in London's wealthiest postcodes. The data, published in The Lancet Diabetes & Endocrinology, invites a reckoning with a society in which a person's health trajectory is increasingly determined by their postcode and income, and where the tools most celebrated as solutions remain out of reach for those who need them most.
- Almost one in three English adults now lives with obesity, but the crisis is not evenly shared — in parts of northeast England, nearly half of all adults are affected, while affluent London neighborhoods sit at 8.5 percent.
- Young adults aged 20 to 39 are bearing the sharpest rise, with new diagnoses climbing up to 20 percent since before the pandemic — a generation building families and careers while carrying compounding health risk.
- Deprivation acts as an accelerant: deprived Asian women developed new obesity cases at rates 94 percent higher than their affluent peers, and deprived Black women aged 60 to 69 show a 66 percent prevalence rate.
- GLP-1 drugs like Ozempic have generated enormous public hope, but NHS data shows no measurable decline in obesity rates since their wider rollout — their cost keeps them largely out of reach for the most vulnerable.
- Experts are calling for systemic reform of food environments, economic conditions, and activity infrastructure, warning that without structural change, obesity will continue to drive surging rates of heart disease, cancer, and diabetes while straining NHS capacity.
A new analysis of NHS electronic health records spanning 2019 to 2025 has produced the most comprehensive picture yet of obesity in England — and what it reveals is not simply a public health crisis, but a deepening map of inequality. Almost one in three English adults now lives with obesity, a figure that has climbed 4 percent since before the pandemic. But the aggregate number obscures a more troubling reality: the burden has become sharply concentrated among the poor, the young, and those living in economically struggling regions.
The geographic divide alone is striking. In some northeast England neighborhoods, nearly half of all adults are obese. In the most affluent parts of central London, that figure falls to 8.5 percent. Researchers at the University of Cambridge and Health Data Research UK describe a gap six times wider than in any comparable area of public health. Layer in ethnicity and class, and the disparities deepen further: among the most economically deprived Black women aged 60 to 69, obesity prevalence reaches 66 percent; among the most affluent White men aged 18 to 19, it drops to just 4 percent.
Young adults have absorbed the steepest increases. Those in their twenties saw new diagnoses rise 16 percent since before the pandemic; those in their thirties, nearly 20 percent. For women of childbearing age, the consequences extend across generations — higher rates of infertility, complicated pregnancies, and children born into the same cycle of risk. Meanwhile, rates among adults aged 60 to 79 actually declined, underscoring that this is a crisis concentrated among those still building their lives.
The pandemic's shadow is visible throughout the data. Lockdowns, economic stress, and disrupted routines hit hardest in places already struggling, and the steepest obesity increases tracked closely with the lowest GDP per capita. Deprivation accelerated new cases by 35 percent overall, 54 percent among women, and 94 percent among deprived Asian women.
GLP-1 receptor agonists like Ozempic have captured public imagination as a potential turning point, but the NHS data shows no measurable decline in obesity rates since their wider use began. The study's co-lead, Robert Fletcher, noted plainly that the drugs remain expensive and largely accessible only through private prescription — a structural barrier that keeps them out of reach for the people most at risk. Professor Naveed Sattar of the University of Glasgow went further, arguing that obesity is not a failure of willpower but a predictable outcome of obesogenic environments where healthy food is scarce, safe exercise is limited, and economic precarity shapes every daily choice. Lasting progress, he and others warn, will require reshaping those environments — not simply expanding access to medication — or the rising toll on hearts, kidneys, and an already stretched NHS will only continue to grow.
Nearly 55 million adults in England's NHS records tell a story of deepening inequality. A new analysis of electronic health data spanning 2019 to 2025 reveals that obesity—once a problem distributed relatively evenly across the country—has become starkly concentrated among the poor, the young, and residents of economically struggling regions. The pandemic accelerated the trend. Today, almost one in three English adults lives with obesity, a threshold that marks a public health crisis of scale rarely seen in modern Britain.
The disparities are almost impossible to ignore. In some neighborhoods of northeast England, nearly half of all adults are obese. Travel south to the most affluent parts of central London, and that figure drops to 8.5 percent. The gap is not a gradual slope but a cliff. Researchers at the University of Cambridge and Health Data Research UK found that obesity prevalence in the northeast runs six times higher than in wealthy London postcodes—a disparity rarely matched in any other area of public health. When you layer in ethnicity and class, the picture becomes even starker. Among the most economically deprived Black women aged 60 to 69, obesity prevalence reaches 66 percent. Among the least deprived White women of the same age, it sits at 33 percent. For the most affluent White men aged 18 to 19, it drops to just 4 percent.
Young adults have been hit hardest by the rising tide. Those aged 20 to 29 saw new obesity diagnoses climb 16 percent since before the pandemic. For those in their thirties, the increase was nearly 20 percent. This matters beyond individual health. Obesity in women of childbearing age carries consequences that ripple across generations: higher rates of infertility, complicated pregnancies, and children born into obesity themselves. The cycle perpetuates. Meanwhile, rates among older adults aged 60 to 79 actually declined, suggesting the crisis is concentrated among those still building their lives and families.
Socioeconomic deprivation acts as an accelerant. People living in the poorest neighborhoods—defined by lowest incomes, highest unemployment, and worst housing—developed new obesity cases at rates 35 percent higher than their affluent counterparts. For women, that gap widened to 54 percent. For Asian women in deprived areas, it reached 94 percent higher. The researchers were careful to note that these figures come from actual clinical diagnoses recorded in NHS systems, not estimates or surveys. The data covers the entire adult population of England, lending it unusual weight and precision.
The pandemic's shadow looms over these numbers. Obesity rates increased 4 percent overall in 2025 compared with pre-COVID levels, but the real story is in the distribution. The virus did not strike all neighborhoods equally, and neither did its aftermath. Lockdowns, disrupted routines, economic stress, and reduced physical activity hit hardest in places already struggling. The researchers found the steepest increases in areas with the lowest GDP per capita—the economically weakest regions.
One drug class has captured public attention: GLP-1 receptor agonists like Ozempic and Wegovy. These medications are genuinely effective at reducing weight. But the data shows no measurable decline in obesity rates since they entered wider use. Robert Fletcher, the study's co-lead, offered a blunt assessment: the drugs are expensive, mostly available through private prescription, and therefore inaccessible to the people most at risk. "The jabs are expensive, which poses a barrier for people from disadvantaged backgrounds," he said. Medication alone cannot solve a problem rooted in environment and economics.
Naveed Sattar, a cardiometabolic medicine professor at the University of Glasgow, reframed the entire conversation. "Obesity is not primarily about will power," he stated. Those most vulnerable to obesity, he argued, live in the most obesogenic environments—neighborhoods where healthy food is scarce or expensive, where safe places to exercise are limited, where stress and economic precarity shape daily life. Lasting change requires not just expanding access to drugs but fundamentally reshaping the food and activity environments in which people live. Without that systemic shift, he warned, the burden of obesity will continue to drive up rates of heart disease, stroke, cancer, diabetes, and kidney failure, straining an already stretched NHS and the broader economy.
The study, published in The Lancet Diabetes & Endocrinology and funded by the Wellcome Trust and other major research bodies, represents the most comprehensive analysis of obesity trends in England to date. It used secure NHS data with all identifying information removed, analyzed by approved researchers in controlled environments. The findings align with household surveys, lending them credibility. What emerges is a portrait of a nation where health outcomes have become increasingly sorted by zip code and bank account, where the young are bearing the heaviest burden, and where the pandemic has widened gaps that were already troublingly wide.
Notable Quotes
The rise in new cases among young adults of childbearing age is especially concerning. Beyond the implications for their own long-term health, obesity is associated with infertility, adverse pregnancy outcomes, and child obesity, which may perpetuate intergenerational cycles of health inequality.— Robert Fletcher, University of Cambridge and Health Data Research UK
Those most at risk frequently reside in the most obesogenic environments and likely have the least agency to withstand such environments. To achieve lasting change, the UK must expand access to new treatments faster but also fundamentally reshape food and activity environments.— Naveed Sattar, University of Glasgow
The Hearth Conversation Another angle on the story
Why does the pandemic matter so much here? Obesity didn't start in 2020.
It didn't, but the pandemic accelerated it. Lockdowns disrupted routines, gyms closed, stress spiked, and economic hardship hit poorest neighborhoods first. The data shows the steepest increases in the weakest economies.
The regional gap is striking—six times higher in the northeast than London. What's actually different about those places?
Poverty, mostly. Lower incomes, higher unemployment, worse housing. But also food environments. In deprived areas, cheap calories are abundant and fresh food is scarce. It's not about willpower; it's about what's available and affordable.
You mentioned young adults are hit hardest. Why does that matter more than older people getting obese?
Because they're building their lives. Obesity in women of childbearing age means infertility, complicated pregnancies, children born into obesity. The cycle perpetuates across generations. It's not just their health; it's the health of people not yet born.
What about these new drugs everyone talks about—Ozempic, Wegovy? Shouldn't they be solving this?
They work for individuals who can afford them. But they're expensive and mostly private. The people most at risk can't access them. And even if they could, drugs alone won't fix an environment that makes obesity inevitable.
So what would actually work?
Systemic change. Reshape food environments so healthy choices are easy and cheap. Create safe places to move in poor neighborhoods. Address the economic stress that drives people toward comfort eating. It's not glamorous, but it's what the evidence points to.
Is this fixable?
Only if there's political will to reshape the environments where people live, not just treat the disease after it arrives. Right now, we're doing the latter and watching inequality widen.